Key result
Single balloon enteroscopy in patients with electronic cardiac devices showed no significant difference in major or minor events, diagnostic yield, or rebleeding compared to controls.
Why the study?
Limited data exist on the utility and safety of single balloon enteroscopy in evaluating obscure overt gastrointestinal bleeding among patients with electronic cardiac devices.
Does single balloon enteroscopy have similar safety and efficacy in patients with electronic cardiac devices compared to those without?
Observational
Does single balloon enteroscopy have similar safety and efficacy in patients with electronic cardiac devices compared to those without?
Single balloon enteroscopy appears safe and effective for evaluating obscure gastrointestinal bleeding in patients with electronic cardiac devices such as LVADs, pacemakers, and ICDs.
Answers are grounded in this paper and cite their sources.
May support similar safety of single balloon enteroscopy in cardiac device patients; leaves open need for randomized confirmation.
OBJECTIVES: Obscure overt gastrointestinal bleeding can be challenging to evaluate in patients with electronic cardiac devices such as continuous flow left ventricular assist devices (LVADs), pacemakers (PPMs), and implantable cardioverter defibrillators (ICDs). Limited data exist on the utility and safety of single balloon enteroscopy (SBE) in patients with cardiac devices. We aimed to evaluate the safety, efficacy, diagnostic, and therapeutic outcomes of the aforementioned devices in patients undergoing SBE. METHODS: Test and logistic regression assessed the association between dependent and independent variables. For continuous data, the results were summarized as mean difference and standard deviation. For dichotomous data, the results were summarized as odds ratio and 95% confidence intervals. There was no statistically significant difference in major or minor events between patients with cardiac devices and the control group. Diagnostic and therapeutic yield and rebleeding rates were similar across both groups. CONCLUSIONS: Patients in the cardiac device group did not appear to be at any more significant risk than those without cardiac devices. Furthermore, diagnostic and therapeutic yield and rebleeding rates appear to be similar across both groups. Clinicians may perform SBE in these patients safely and effectively, with good overall outcomes.
No takes yet. Share an insight, caveat, or question.
Patel et al. (2019) conducted an observational in Obscure overt gastrointestinal bleeding. Electronic cardiac devices (LVADs, PPMs, ICDs) vs. Patients without cardiac devices was evaluated on Major or minor events (p== 0.049). Single balloon enteroscopy in patients with electronic cardiac devices showed no significant difference in major or minor events, diagnostic yield, or rebleeding compared to controls.
Synapse has enriched 10 related papers. Consider them for comparative context: